Literature DB >> 24833099

Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center.

Huabin Yin1, Wang Zhou, Jia Meng, Dan Zhang, Zhipeng Wu, Ting Wang, Jing Wang, Peng Wang, Xin Shi, Sujia Wu, Jianning Zhao, Jianru Xiao.   

Abstract

PURPOSE: Chondrosarcoma (CHS) in the spine is relatively rare and minimal information has been published in the literature regarding this subject. The objective of our study was to discuss the factors that may affect outcomes of patients with spinal CHS.
METHODS: Univariate and multivariate analyses were performed to identify prognostic factors for recurrence, distant metastasis, and survival of spinal CHS. T test, χ (2) test and rank sum test were used to analyze a single factor for recurrence and metastasis, while survival rate was estimated using the Kaplan-Meier method. Factors with p values of ≤0.1 were subjected to multivariate analyses by binary logistic regression analyses or Cox regression analyses. p Values of ≤0.05 were considered statistically significant.
RESULTS: A total of 98 patients with spinal CHS were included in the study. The mean follow-up period was 49.7 months (range 6-178). Recurrence was detected in 42 patients after initial surgery in our center, while distant metastasis and death occurred in 24 and 32 cases, respectively. The statistical analyses suggested that pathology grade III was closely related with distant metastasis which was an independent prognostic factor for overall survival. Total en bloc spondylectomy could significantly decrease the risk of recurrence, distant metastasis, and death of patients with spinal CHS.
CONCLUSIONS: Total en bloc spondylectomy could significantly decrease the risk of recurrence and distant metastasis, and meanwhile improve overall survival of spinal CHS. Distant metastasis which was closely associated with pathology grade III was an adverse prognostic factor for overall survival of spinal CHS.

Entities:  

Mesh:

Year:  2014        PMID: 24833099     DOI: 10.1245/s10434-014-3745-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  14 in total

1.  Treatment and outcome of malignant giant cell tumor in the spine.

Authors:  Huabin Yin; Mo Cheng; Bo Li; Binbin Li; Peng Wang; Tong Meng; Jing Wang; Wang Zhou; Wangjun Yan; Jianru Xiao
Journal:  J Neurooncol       Date:  2015-06-04       Impact factor: 4.130

2.  Factors affecting survival outcomes of patients with non-metastatic Ewing's sarcoma family tumors in the spine: a retrospective analysis of 63 patients in a single center.

Authors:  Wei Wan; Yan Lou; Zhiqi Hu; Ting Wang; Jinsong Li; Yu Tang; Zhipeng Wu; Leqin Xu; Xinghai Yang; Dianwen Song; Jianru Xiao
Journal:  J Neurooncol       Date:  2016-10-17       Impact factor: 4.130

3.  Treatment and outcome of primary aggressive giant cell tumor in the spine.

Authors:  Huabin Yin; Xinghai Yang; Wei Xu; Binbin Li; Bo Li; Ting Wang; Tong Meng; Peng Wang; Tielong Liu; Wang Zhou; Jianru Xiao
Journal:  Eur Spine J       Date:  2015-01-29       Impact factor: 3.134

4.  What is the Incidence of Suicide in Patients with Bone and Soft Tissue Cancer? : Suicide and Sarcoma.

Authors:  Brianna L Siracuse; George Gorgy; Jeremy Ruskin; Kathleen S Beebe
Journal:  Clin Orthop Relat Res       Date:  2016-11-28       Impact factor: 4.176

5.  Clinical significance of traditional clinical parameters and inflammatory biomarkers for the prognosis of patients with spinal chondrosarcoma: a retrospective study of 150 patients in a single center.

Authors:  Kehan Xu; Bo Li; Quan Huang; Dongjie Jiang; Haitao Sun; Nanzhe Zhong; Wei Wan; Haifeng Wei; Jianru Xiao
Journal:  Eur Spine J       Date:  2019-05-04       Impact factor: 3.134

6.  Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center.

Authors:  Tong Meng; Huabin Yin; Bo Li; Zhenxi Li; Wei Xu; Wang Zhou; Mo Cheng; Jing Wang; Lei Zhou; Xinghai Yang; Tielong Liu; Wangjun Yan; Dianwen Song; Jianru Xiao
Journal:  Neuro Oncol       Date:  2014-12-08       Impact factor: 12.300

7.  Physical Function and Quality of Life After Resection of Mobile Spine Chondrosarcoma.

Authors:  Nuno Rui Paulino Pereira; Stein J Janssen; Nicky Stoop; Stefan Hartveldt; Yen-Lin E Chen; Thomas F DeLaney; Francis J Hornicek; Joseph H Schwab
Journal:  Global Spine J       Date:  2019-02-18

8.  Prognostic Factors for Survival in Patients with Malignant Giant Cell Tumor of Bone: A Risk Nomogram Analysis Based on the Population.

Authors:  Xiaolong Zhu; Runzhi Huang; Peng Hu; Penghui Yan; Suna Zhai; Jie Zhang; Junwei Zhuang; Huabin Yin; Tong Meng; Daoke Yang; Zongqiang Huang
Journal:  Med Sci Monit       Date:  2021-02-17

9.  The Clinical Characteristics and Prediction Nomograms for Primary Spine Malignancies.

Authors:  Lei Zhou; Runzhi Huang; Ziheng Wei; Tong Meng; Huabin Yin
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

10.  Clinical Statistical Analysis with Comparison between Pelvic and Non-pelvic Chondrosarcoma.

Authors:  Sayed Abdulla Jami; Shi Jiandang; Brotendu Shekhar Roy; Zhanwen Zhou; Liu Chang Hao
Journal:  Oman Med J       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.